Tag: survodutide

Medical illustration showing weight loss medication injection and clinical trial results
Clinical UpdatesNew StudiesPracticeResearch Digest

Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial

Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in over 3,400 adults with obesity.…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →